文献速递肥胖与代谢综合征糖尿病

PLIN1单倍剂量不足导致有利的代谢表型

PLIN1 Haploinsufficiency Causes a Favorable Metabolic Profile.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

研究利用英国生物银行362791人外显子数据及T2D知识门户43125人数据,发现735名PLIN1蛋白截短变异携带者具有更有利的代谢谱,包括高密度脂蛋白胆固醇升高、甘油三酯降低、腰臀比降低和收缩压降低,并与心肌梗死和高血压风险降低相关,但与2型糖尿病风险无关。

要点

  • PLIN1蛋白截短变异携带者高密度脂蛋白胆固醇升高0.12 mmol/L,甘油三酯降低0.22 mmol/L。
  • 携带者腰臀比降低0.02,收缩压降低1.67 mm Hg,心肌梗死风险OR=0.59。
  • PLIN1单倍剂量不足可能与心血管疾病风险降低相关,但与2型糖尿病风险无关。

核心结论

  • 研究提示PLIN1单倍剂量不足导致有利的代谢表型,并可能预防心血管疾病。

研究设计与样本

  • 基于英国生物银行362791名个体外显子数据的基因负荷关联研究,并在T2D知识门户43125名个体中重复关联。

主要发现

  • 735名PLIN1蛋白截短变异携带者高密度脂蛋白胆固醇升高0.12 mmol/L(95% CI 0.09至0.14,P=2×10^-18)。
  • 携带者甘油三酯降低0.22 mmol/L(95% CI -0.29至-0.14,P=3×10^-11),腰臀比降低0.02(95% CI -0.02至-0.01,P=9×10^-12)。
  • 携带者收缩压降低1.67 mm Hg(95% CI -3.25至-0.09,P=.05)。
  • 在英国生物银行中,PLIN1蛋白截短变异与心肌梗死风险降低相关(OR=0.59;95% CI 0.35至0.93,P=.02),与高血压风险降低相关(OR=0.85;95% CI 0.73至0.98,P=.03),与2型糖尿病风险无关(OR=0.99;95% CI 0.63至1.51,P=.99)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: PLIN1 encodes perilipin-1, which coats lipid droplets in adipocytes and is involved in droplet formation, triglyceride storage, and lipolysis. Rare PLIN1 frameshift variants that extend the translated protein have been described to cause lipodystrophy. OBJECTIVE: This work aimed to test whether PLIN1 protein-truncating variants (PTVs) cause lipodystrophy in a large population-based cohort. METHODS: We identified individuals with PLIN1 PTVs in individuals with exome data in the UK Biobank. We performed gene-burden testing for individuals with PLIN1 PTVs. We replicated the associations using data from the T2D Knowledge portal. We performed a phenome-wide association study using publicly available association statistics. A total of 362 791 individuals in the UK Biobank, a population-based cohort, and 43 125 individuals in the T2D Knowledge portal, a type 2 diabetes (T2D) case-control study, were included in the analyses. Main outcome measures included 22 diseases and traits relevant to lipodystrophy. RESULTS: The 735 individuals with PLIN1 PTVs had a favorable metabolic profile. These individuals had increased high-density lipoprotein cholesterol (0.12 mmol/L; 95% CI, 0.09 to 0.14, P = 2 × 10-18), reduced triglycerides (-0.22 mmol/L; 95% CI, -0.29 to -0.14, P = 3 × 10-11), reduced waist-to-hip ratio (-0.02; 95% CI, -0.02 to -0.01, P = 9 × 10-12), and reduced systolic blood pressure (-1.67 mm Hg; 95% CI, -3.25 to -0.09, P = .05). These associations were consistent in the smaller T2D Knowledge portal cohort. In the UK Biobank, PLIN1 PTVs were associated with reduced risk of myocardial infarction (odds ratio [OR] = 0.59; 95% CI, 0.35 to 0.93, P = .02) and hypertension (OR = 0.85; 95% CI, 0.73 to 0.98, P = .03), but not T2D (OR = 0.99; 95% CI, 0.63-1.51, P = .99). CONCLUSION: Our study suggests that PLIN1 haploinsufficiency causes a favorable metabolic profile and may protect against cardiovascular disease.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Patel KA, Burman S, Laver TW, et al. PLIN1 Haploinsufficiency Causes a Favorable Metabolic Profile. J Clin Endocrinol Metab. 2022. PMID: 35235652. doi:10.1210/clinem/dgac104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。